Cell and Gene Outsourcing

  1. Optimizing Viability And Standardization For Clinical Excellence 10/2/2024

    Explore how IntegriCell™ delivers high-quality, manufacture-ready cryopreserved leukopaks, vital for consistent and reliable cell therapy production.

  2. Mitigating Risk Through Product Characterization 7/17/2019

    In this webinar, multiple approaches to characterizing the physico-chemical and structural attributes of therapeutic mAbs is presented with a focus on how it influences the resulting biological activity.

  3. Optimizing Monoclonal Antibody Manufacturing For Commercial Success

    Strategically optimize your upstream and downstream processes and decrease the timeline from optimization to commercial manufacturing.

  4. Eliminate Risk From Your Viral Vector Tech Transfers 12/5/2025

    Explore strategies to simplify viral vector tech transfers, reduce risk, and maintain quality under tight timelines, as well as a case study that demonstrates how to streamline this critical process.

  5. Early Preclinical Development: A Successful Transition To cGMP Manufacturing 12/2/2024

    Explore the development steps that lead to an mRNA construct optimized for your requirements and that meets future-proof cGMP manufacturing requirements, thereby de-risking the development.

  6. Innovating Upstream Manufacturing For The Next Wave Of Gene Therapies 3/4/2026

    Explore a streamlined approach to transient AAV production, including yield improvements across serotypes, key transfection parameters, and practical guidance for scaling processes.

  7. Meeting Needs And Exceeding Expectations Worldwide 10/16/2024

    Whether you are looking to optimize your existing formulations or require full-scale manufacturing solutions, Boehringer Ingelheim BioXcellence™ is dedicated to helping you realize your vision and deliver impactful therapies.

  8. Meet The Experts: Part 3 - Chemometrics And Model Building 5/1/2023

    Watch part 3 of this 4-part interview series to learn about chemometrics and model building from expert Johan Cailletaud.

  9. Evaluating Viral Clearance For Continuous Processes 10/18/2020

    Is viral clearance a hurdle to implementing continuous processing? Here we share virus spiking alternatives that may pave the way for evaluating viral clearance by chromatography steps.

  10. Similar Enough Product Characterization To Support Process Changes And Biosimilar Development

    Characterization is essential to understand the impact following process changes and successful biosimilar development. Here, we provide best approaches for comparability studies.